{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T11:55:09Z","timestamp":1775130909444,"version":"3.50.1"},"reference-count":98,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CHAMC"],"published-print":{"date-parts":[[2020,10,15]]},"abstract":"<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>Cryptogenic stroke and its relation to the Patent Foramen Ovale (PFO) is a long-debated\ntopic. Recent clinical trials have unequivocally established the relationship between cryptogenic\nstrokes and paradoxical embolism across the PFO. This slit-like communication exists in everyone\nbefore birth, but most often closes shortly after birth. PFO may persist as a narrow channel of communication\nbetween the right and left atria in approximately 25-27% of adults.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>In this review, we examine the clinical relevance of the PFO with analysis of the latest trials evaluating\ncatheter-based closure of PFO\u2019s for cryptogenic stroke. We also review the current evidence examining\nthe use of antiplatelet medications versus anticoagulants for stroke prevention in those patients\nwith PFO who do not qualify for closure per current guidelines.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871525718666200203111641","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T07:19:10Z","timestamp":1581059950000},"page":"135-150","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Patent Foramen Ovale, the Role of Antiplatelet Therapy Alone or Anticoagulant Therapy Alone Versus Device Closure for Cryptogenic Stroke: A Review of the Literature and Current Recommendations"],"prefix":"10.2174","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8560-939X","authenticated-orcid":true,"given":"Harsha S.","family":"Nagarajarao","sequence":"first","affiliation":[{"name":"Department of Medicine, Texas Tech University of Health Sciences, El Paso, TX, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2490-523X","authenticated-orcid":true,"given":"Chandra P.","family":"Ojha","sequence":"additional","affiliation":[{"name":"Department of Medicine, Texas Tech University of Health Sciences, El Paso, TX, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8429-7021","authenticated-orcid":true,"given":"Archana","family":"Kedar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Clinical Instructor, University of Louisville, Kentucky, Louisville, Kentucky, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3678-0593","authenticated-orcid":true,"given":"Debabrata","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Department of Medicine, Texas Tech University of Health Sciences, El Paso, TX, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0025-6196(12)60336-X","volume":"59","author":"Hagen P.T.","year":"1984","unstructured":"Hagen P.T.; Scholz D.G.; Edwards W.D.; Incidence and size of patent foramen ovale during the first 10 decades of life: An autopsy study of 965 normal hearts. Mayo Clin Proc 1984,59(1),17-20","journal-title":"Mayo Clin Proc"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJM198805053181802","volume":"318","author":"Lechat P.","year":"1988","unstructured":"Lechat P.; Mas J.L.; Lascault G.; Loron P.; Theard M.; Klimczac M.; Drobinski G.; Thomas D.; Grosgogeat Y.; Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988,318(18),1148-1152","journal-title":"N Engl J Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1161\/01.CIR.0000017498.88393.44","volume":"105","author":"Homma S.","year":"2002","unstructured":"Homma S.; Sacco R.L.; Di Tullio M.R.; Sciacca R.R.; Mohr J.P.; Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002,105(22),2625-2631","journal-title":"Circulation"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0140-6736(88)92944-3","volume":"2","author":"Webster M.W.","year":"1988","unstructured":"Webster M.W.; Chancellor A.M.; Smith H.J.; Swift D.L.; Sharpe D.N.; Bass N.M.; Glasgow G.L.; Patent foramen ovale in young stroke patients. Lancet 1988,2(8601),11-12","journal-title":"Lancet"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1161\/01.STR.24.12.1865","volume":"24","author":"Cabanes L.","year":"1993","unstructured":"Cabanes L.; Mas J.L.; Cohen A.; Amarenco P.; Cabanes P.A.; Oubary P.; Chedru F.; Gu\u00e9rin F.; Bousser M.G.; de Recondo J.; Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 1993,24(12),1865-1873","journal-title":"Stroke"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1161\/01.STR.24.1.31","volume":"24","author":"Ranoux D.","year":"1993","unstructured":"Ranoux D.; Cohen A.; Cabanes L.; Amarenco P.; Bousser M.G.; Mas J.L.; Patent foramen ovale: is stroke due to paradoxical embolism? Stroke 1993,24(1),31-34","journal-title":"Stroke"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1212\/WNL.52.8.1622","volume":"52","author":"Anzola G.P.","year":"1999","unstructured":"Anzola G.P.; Magoni M.; Guindani M.; Rozzini L.; Dalla Volta G.; Potential source of cerebral embolism in migraine with aura: A transcranial Doppler study. Neurology 1999,52(8),1622-1625","journal-title":"Neurology"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000047758","volume":"13","author":"Sztajzel R.","year":"2002","unstructured":"Sztajzel R.; Genoud D.; Roth S.; Mermillod B.; Le Floch-Rohr J.; Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke. Cerebrovasc Dis 2002,13(2),102-106","journal-title":"Cerebrovasc Dis"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1111\/j.1526-4610.2010.01621.x","volume":"50","author":"Caputi L.","year":"2010","unstructured":"Caputi L.; Usai S.; Carriero M.R.; Grazzi L.; D\u2019Amico D.; Falcone C.; Anzola G.P.; Del Sette M.; Parati E.; Bussone G.; Microembolic air load during contrast-transcranial Doppler: A trigger for migraine with aura? Headache 2010,50(8),1320-1327","journal-title":"Headache"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1177\/146642408810800417","volume":"108","author":"Wilmshurst P.","year":"1988","unstructured":"Wilmshurst P.; Decompression sickness. J R Soc Health 1988,108(4),152","journal-title":"J R Soc Health"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1016\/S0140-6736(00)03160-3","volume":"356","author":"Wilmshurst P.T.","year":"2000","unstructured":"Wilmshurst P.T.; Nightingale S.; Walsh K.P.; Morrison W.L.; Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000,356(9242),1648-1651","journal-title":"Lancet"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/bmj.309.6961.1029","volume":"309","author":"Wilmshurst P.","year":"1994","unstructured":"Wilmshurst P.; Medical aspects of scuba diving. Decompression sickness may be due to paradoxical embolism. BMJ 1994,309(6950),340","journal-title":"BMJ"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0140-6736(89)92251-4","volume":"1","author":"Wilmshurst P.T.","year":"1989","unstructured":"Wilmshurst P.T.; Byrne J.C.; Webb-Peploe M.M.; Neurological decompression sickness. Lancet 1989,1(8640),731","journal-title":"Lancet"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/S0140-6736(89)91911-9","volume":"2","author":"Wilmshurst P.T.","year":"1989","unstructured":"Wilmshurst P.T.; Byrne J.C.; Webb-Peploe M.M.; Relation between interatrial shunts and decompression sickness in divers. Lancet 1989,2(8675),1302-1306","journal-title":"Lancet"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/0140-6736(90)92546-T","volume":"336","author":"Wilmshurst P.","year":"1990","unstructured":"Wilmshurst P.; Right-to-left shunt and neurological decompression sickness in divers. Lancet 1990,336(8722),1071-1072","journal-title":"Lancet"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.jtcvs.2007.10.090","volume":"136","author":"Choong C. K.","year":"2008","unstructured":"Choong C. K.; Calvert P. A.; Falter F.; Mathur R.; Appleton D.; Wells F. C.; Schofield P. M.; Crawford R.; Life-threatening impending\nparadoxical embolus caught \u201cred-handed\u201d: Successful management\nby multidisciplinary team approach.  J Thorac Cardiovasc\nSurg, 2008,136(2),527-528 e8","journal-title":"J Thorac Cardiovasc\nSurg,"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1016\/j.ijcard.2007.06.116","volume":"129","author":"Kim R.J.","year":"2008","unstructured":"Kim R.J.; Girardi L.N.; Lots of clots: Multiple thromboemboli including a huge paradoxical embolus in a 29-year old man. Int J Cardiol 2008,129(2),e50-e52","journal-title":"Int J Cardiol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1136\/emj.2006.045104","volume":"24","author":"Madani H.","year":"2007","unstructured":"Madani H.; Ransom P.A.; Paradoxical embolus illustrating speed of action of recombinant tissue plasminogen activator in massive pulmonary embolism. Emerg Med J 2007,24(6),441","journal-title":"Emerg Med J"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1161\/CIRCULATIONAHA.107.727271","volume":"117","author":"Dowson A.","year":"2008","unstructured":"Dowson A.; Mullen M.J.; Peatfield R.; Muir K.; Khan A.A.; Wells C.; Lipscombe S.L.; Rees T.; De Giovanni J.V.; Morrison W.L.; Hildick-Smith D.; Elrington G.; Hillis W.S.; Malik I.S.; Rickards A.; Migraine intervention with STARFlex technology (MIST) trial: A prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008,117(11),1397-1404","journal-title":"Circulation"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1378\/chest.113.1.91","volume":"113","author":"Shanoudy H.","year":"1998","unstructured":"Shanoudy H.; Soliman A.; Raggi P.; Liu J.W.; Russell D.C.; Jarmukli N.F.; Prevalence of patent foramen ovale and its contribution to hypoxemia in patients with obstructive sleep apnea. Chest 1998,113(1),91-96","journal-title":"Chest"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","volume":"377","author":"Mas J.L.","year":"2017","unstructured":"Mas J.L.; Derumeaux G.; Guillon B.; Massardier E.; Hosseini H.; Mechtouff L.; Arquizan C.; B\u00e9jot Y.; Vuillier F.; Detante O.; Guidoux C.; Canaple S.; Vaduva C.; Dequatre-Ponchelle N.; Sibon I.; Garnier P.; Ferrier A.; Timsit S.; Robinet-Borgomano E.; Sablot D.; Lacour J.C.; Zuber M.; Favrole P.; Pinel J.F.; Apoil M.; Reiner P.; Lefebvre C.; Gu\u00e9rin P.; Piot C.; Rossi R.; Dubois-Rand\u00e9 J.L.; Eicher J.C.; Meneveau N.; Lusson J.R.; Bertrand B.; Schleich J.M.; Godart F.; Thambo J.B.; Leborgne L.; Michel P.; Pierard L.; Turc G.; Barthelet M.; Charles-Nelson A.; Weimar C.; Moulin T.; Juliard J.M.; Chatellier G.; Investigators C.; Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med 2017,377(11),1011-1021","journal-title":"N Engl J Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","volume":"377","author":"Saver J.L.","year":"2017","unstructured":"Saver J.L.; Carroll J.D.; Thaler D.E.; Smalling R.W.; MacDonald L.A.; Marks D.S.; Tirschwell D.L.; Investigators R.; Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med 2017,377(11),1022-1032","journal-title":"N Engl J Med"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","volume":"377","author":"S\u00f8ndergaard L.","year":"2017","unstructured":"S\u00f8ndergaard L.; Kasner S.E.; Rhodes J.F.; Andersen G.; Iversen H.K.; Nielsen-Kudsk J.E.; Settergren M.; Sj\u00f6strand C.; Roine R.O.; Hildick-Smith D.; Spence J.D.; Thomassen L.; Gore R.C.S.I.; Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med 2017,377(11),1033-1042","journal-title":"N Engl J Med"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1016\/j.jacc.2018.02.046","volume":"71","author":"Lee P.H.","year":"2018","unstructured":"Lee P.H.; Song J.K.; Kim J.S.; Heo R.; Lee S.; Kim D.H.; Song J.M.; Kang D.H.; Kwon S.U.; Kang D.W.; Lee D.; Kwon H.S.; Yun S.C.; Sun B.J.; Park J.H.; Lee J.H.; Jeong H.S.; Song H.J.; Kim J.; Park S.J.; Cryptogenic stroke and high-risk patent foramen ovale: The DEFENSE-PFO trial. J Am Coll Cardiol 2018,71(20),2335-2342","journal-title":"J Am Coll Cardiol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"k2515","DOI":"10.1136\/bmj.k2515","volume":"362","author":"Kuijpers T.","year":"2018","unstructured":"Kuijpers T.; Spencer F.A.; Siemieniuk R.A.C.; Vandvik P.O.; Otto C.M.; Lytvyn L.; Mir H.; Jin A.Y.; Manja V.; Karthikeyan G.; Hoendermis E.; Martin J.; Carballo S.; O\u2019Donnell M.; Vartdal T.; Baxter C.; Patrick-Lake B.; Scott J.; Agoritsas T.; Guyatt G.; Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline. BMJ 2018,362,k2515","journal-title":"BMJ"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1159\/000131083","volume":"25","year":"2008","unstructured":"Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008,25(5),457-507","journal-title":"Cerebrovasc Dis"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1212\/WNL.0000000000002961","volume":"87","author":"Mess\u00e9 S.R.","year":"2016","unstructured":"Mess\u00e9 S.R.; Gronseth G.; Kent D.M.; Kizer J.R.; Homma S.; Rosterman L.; Kasner S.E.; Practice advisory: Recurrent stroke with patent foramen ovale (update of practice parameter): Report of the guideline development, dissemination, and implementation subcommittee of the American academy of neurology. Neurology 2016,87(8),815-821","journal-title":"Neurology"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1161\/01.CIR.86.6.1902","volume":"86","author":"Bridges N.D.","year":"1992","unstructured":"Bridges N.D.; Hellenbrand W.; Latson L.; Filiano J.; Newburger J.W.; Lock J.E.; Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992,86(6),1902-1908","journal-title":"Circulation"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/ccd.24875","volume":"82","author":"Abaci A.","year":"2013","unstructured":"Abaci A.; Unlu S.; Alsancak Y.; Kaya U.; Sezenoz B.; Short and long term complications of device closure of atrial septal defect and patent foramen ovale: Meta-analysis of 28,142 patients from 203 studies. Catheter Cardiovasc Interv 2013,82(7),1123-1138","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa1009639","volume":"366","author":"Furlan A.J.","year":"2012","unstructured":"Furlan A.J.; Reisman M.; Massaro J.; Mauri L.; Adams H.; Albers G.W.; Felberg R.; Herrmann H.; Kar S.; Landzberg M.; Raizner A.; Wechsler L.; Investigators C.I.; Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 2012,366(11),991-999","journal-title":"N Engl J Med"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1046\/j.1540-8183.2003.08001.x","volume":"16","author":"Morandi E.","year":"2003","unstructured":"Morandi E.; Anzola G.P.; Angeli S.; Melzi G.; Onorato E.; Transcatheter closure of patent foramen ovale: A new migraine treatment? J Interv Cardiol 2003,16(1),39-42","journal-title":"J Interv Cardiol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nrcardio.2010.224","volume":"8","author":"Calvert P.A.","year":"2011","unstructured":"Calvert P.A.; Rana B.S.; Kydd A.C.; Shapiro L.M.; Patent foramen ovale: Anatomy, outcomes, and closure. Nat Rev Cardiol 2011,8(3),148-160","journal-title":"Nat Rev Cardiol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"i19","DOI":"10.1093\/ejechocard\/jeq122","volume":"11","author":"Rana B.S.","year":"2010","unstructured":"Rana B.S.; Shapiro L.M.; McCarthy K.P.; Ho S.Y.; Three dimensional imaging of the atrial septum and patent foramen ovale anatomy: defining the morphological phenotypes of patent foramen ovale. Eur J Echocardiogr 2010,11(10),i19-i25","journal-title":"Eur J Echocardiogr"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0735-1097(95)00144-O","volume":"26","author":"Schneider B.","year":"1995","unstructured":"Schneider B.; Hofmann T.; Justen M.H.; Meinertz T.; Chiari\u2019s network: normal anatomic variant or risk factor for arterial embolic events? J Am Coll Cardiol 1995,26(1),203-210","journal-title":"J Am Coll Cardiol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1161\/01.STR.29.5.944","volume":"29","author":"Steiner M.M.","year":"1998","unstructured":"Steiner M.M.; Di Tullio M.R.; Rundek T.; Gan R.; Chen X.; Liguori C.; Brainin M.; Homma S.; Sacco R.L.; Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke 1998,29(5),944-948","journal-title":"Stroke"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/echo.12462","volume":"31","author":"Mojadidi M.K.","year":"2014","unstructured":"Mojadidi M.K.; Bogush N.; Caceres J.D.; Msaouel P.; Tobis J.M.; Diagnostic accuracy of transesophageal echocardiogram for the detection of patent foramen ovale: A meta-analysis. Echocardiography 2014,31(6),752-758","journal-title":"Echocardiography"},{"key":"ref=37","first-page":"495","volume":"6","author":"Mahmoud A.N.","year":"2017","unstructured":"Mahmoud A.N.; Elgendy I.Y.; Agarwal N.; Tobis J.M.; Mojadidi M.K.; Identification and quantification of patent foramen ovale mediated shunts: Echocardiography and transcranial Doppler. Interv Cardiol Clin 2017,6(4),495-504","journal-title":"Interv Cardiol Clin"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.echo.2017.05.006","volume":"30","author":"Mojadidi M.K.","year":"2017","unstructured":"Mojadidi M.K.; Mahmoud A.N.; Elgendy I.Y.; Agarwal N.; Tobis J.M.; Transesophageal echocardiography for the detection of patent foramen ovale. J Am Soc Echocardiogr 2017,30(9),933-934","journal-title":"J Am Soc Echocardiogr"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/0735-1097(91)90705-E","volume":"17","author":"Pearson A.C.","year":"1991","unstructured":"Pearson A.C.; Labovitz A.J.; Tatineni S.; Gomez C.R.; Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology. J Am Coll Cardiol 1991,17(1),66-72","journal-title":"J Am Coll Cardiol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1161\/01.STR.22.6.734","volume":"22","author":"Lee R.J.","year":"1991","unstructured":"Lee R.J.; Bartzokis T.; Yeoh T.K.; Grogin H.R.; Choi D.; Schnittger I.; Enhanced detection of intracardiac sources of cerebral emboli by transesophageal echocardiography. Stroke 1991,22(6),734-739","journal-title":"Stroke"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0894-7317(14)80240-X","volume":"6","author":"Chenzbraun A.","year":"1993","unstructured":"Chenzbraun A.; Pinto F.J.; Schnittger I.; Biplane transesophageal echocardiography in the diagnosis of patent foramen ovale. J Am Soc Echocardiogr 1993,6(4),417-421","journal-title":"J Am Soc Echocardiogr"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jcmg.2013.12.011","volume":"7","author":"Mojadidi M.K.","year":"2014","unstructured":"Mojadidi M.K.; Roberts S.C.; Winoker J.S.; Romero J.; Goodman-Meza D.; Gevorgyan R.; Tobis J.M.; Accuracy of transcranial Doppler for the diagnosis of intracardiac right-to-left shunt: a bivariate meta-analysis of prospective studies. JACC Cardiovasc Imaging 2014,7(3),236-250","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/echo.13231","volume":"33","author":"Mojadidi M.K.","year":"2016","unstructured":"Mojadidi M.K.; Zhang L.; Chugh Y.; Eshtehardi P.; Hovnanians N.; Gevorgyan R.; Mojaddedi S.; Nezami N.; Zaman M.O.; Rafique A.; Villablanca P.A.; Tobis J.M.; Transcranial Doppler: Does addition of blood to agitated saline affect sensitivity for detecting cardiac right-to-left shunt? Echocardiography 2016,33(8),1219-1227","journal-title":"Echocardiography"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.0742-2822.2004.02168.x","volume":"21","author":"Madala D.","year":"2004","unstructured":"Madala D.; Zaroff J.G.; Hourigan L.; Foster E.; Harmonic imaging improves sensitivity at the expense of specificity in the detection of patent foramen ovale. Echocardiography 2004,21(1),33-36","journal-title":"Echocardiography"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s10554-014-0426-8","volume":"30","author":"Mojadidi M.K.","year":"2014","unstructured":"Mojadidi M.K.; Winoker J.S.; Roberts S.C.; Msaouel P.; Gevorgyan R.; Zolty R.; Two-dimensional echocardiography using second harmonic imaging for the diagnosis of intracardiac right-to-left shunt: a meta-analysis of prospective studies. Int J Cardiovasc Imaging 2014,30(5),911-923","journal-title":"Int J Cardiovasc Imaging"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.echo.2009.06.008","volume":"22","author":"Taniguchi M.","year":"2009","unstructured":"Taniguchi M.; Akagi T.; Watanabe N.; Okamoto Y.; Nakagawa K.; Kijima Y.; Toh N.; Ohtsuki S.; Kusano K.; Sano S.; Application of real-time three-dimensional transesophageal echocardiography using a matrix array probe for transcatheter closure of atrial septal defect. J Am Soc Echocardiogr 2009,22(10),1114-1120","journal-title":"J Am Soc Echocardiogr"},{"key":"ref=47","first-page":"38","volume":"3","author":"Bartel T.","year":"2013","unstructured":"Bartel T.; M\u00fcller S.; Contemporary echocardiographic guiding tools for device closure of interatrial communications. Cardiovasc Diagn Ther 2013,3(1),38-46","journal-title":"Cardiovasc Diagn Ther"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/0002-8703(94)90626-2","volume":"128","author":"Belkin R.N.","year":"1994","unstructured":"Belkin R.N.; Pollack B.D.; Ruggiero M.L.; Alas L.L.; Tatini U.; Comparison of transesophageal and transthoracic echocardiography with contrast and color flow Doppler in the detection of patent foramen ovale. Am Heart J 1994,128(3),520-525","journal-title":"Am Heart J"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"pp. 166","DOI":"10.1016\/s0002-9149(00)80068-5","volume":"75","author":"Sansoy V.","year":"1995","unstructured":"Sansoy V.; Low yield of transthoracic echocardiography for cardiac source of embolism. Am J Cardiol , et al. 1995,75(2),pp. 166-169","journal-title":"Am J Cardiol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1056\/NEJMoa011503","volume":"345","author":"Mas J.L.","year":"2001","unstructured":"Mas J.L.; Arquizan C.; Lamy C.; Zuber M.; Cabanes L.; Derumeaux G.; Coste J.; Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001,345(24),1740-1746","journal-title":"N Engl J Med"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/S0002-9343(00)00530-1","volume":"109","author":"Schuchlenz H.W.","year":"2000","unstructured":"Schuchlenz H.W.; Weihs W.; Horner S.; Quehenberger F.; The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. Am J Med 2000,109(6),456-462","journal-title":"Am J Med"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/0735-1097(93)90789-4","volume":"22","author":"Gin K.G.","year":"1993","unstructured":"Gin K.G.; Huckell V.F.; Pollick C.; Femoral vein delivery of contrast medium enhances transthoracic echocardiographic detection of patent foramen ovale. J Am Coll Cardiol 1993,22(7),1994-2000","journal-title":"J Am Coll Cardiol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/S0735-1097(03)00907-0","volume":"42","author":"Homma S.","year":"2003","unstructured":"Homma S.; Sacco R.L.; Di Tullio M.R.; Sciacca R.R.; Mohr J.P.; Atrial anatomy in non-cardioembolic stroke patients: Effect of medical therapy. J Am Coll Cardiol 2003,42(6),1066-1072","journal-title":"J Am Coll Cardiol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/ehjci\/jet048","volume":"14","author":"Bartel T.","year":"2013","unstructured":"Bartel T.; M\u00fcller S.; Device closure of interatrial communications: peri-interventional echocardiographic assessment. Eur Heart J Cardiovasc Imaging 2013,14(7),618-624","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"633","DOI":"10.2459\/01.JCM.0000281705.69230.ff","volume":"8","author":"Rigatelli G.","year":"2007","unstructured":"Rigatelli G.; Cardaioli P.; Braggion G.; Giordan M.; Aggio S.; Roncon L.; ICE-guided Patent Foramen Ovale (PFO) closure with lastest-generation devices: The ideal strategy for PFO-related migraine? J Cardiovasc Med (Hagerstown) 2007,8(8),633-635","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1161\/01.CIR.0000057547.00909.1C","volume":"107","author":"Bartel T.","year":"2003","unstructured":"Bartel T.; Konorza T.; Arjumand J.; Ebradlidze T.; Eggebrecht H.; Caspari G.; Neudorf U.; Erbel R.; Intracardiac echocardiography is superior to conventional monitoring for guiding device closure of interatrial communications. Circulation 2003,107(6),795-797","journal-title":"Circulation"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.euje.2004.07.007","volume":"6","author":"Bartel T.","year":"2005","unstructured":"Bartel T.; Konorza T.; Neudorf U.; Ebralize T.; Eggebrecht H.; Gutersohn A.; Erbel R.; Intracardiac echocardiography: An ideal guiding tool for device closure of interatrial communications. Eur J Echocardiogr 2005,6(2),92-96","journal-title":"Eur J Echocardiogr"},{"key":"ref=58","author":"Cohnheim J.","year":"1877","unstructured":"Cohnheim J.; Cohnheim J.; Thrombose und embolie.  Vorlesungen\nu \u0308 berAllgemeine Pathologie Hirschwald: Berlin 1, p. 134. 1877","journal-title":"Vorlesungen\nu \u0308 berAllgemeine Pathologie"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-117-6-461","volume":"117","author":"Di Tullio M.","year":"1992","unstructured":"Di Tullio M.; Sacco R.L.; Gopal A.; Mohr J.P.; Homma S.; Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992,117(6),461-465","journal-title":"Ann Intern Med"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1161\/01.STR.19.5.547","volume":"19","author":"Foulkes M.A.","year":"1988","unstructured":"Foulkes M.A.; Wolf P.A.; Price T.R.; Mohr J.P.; Hier D.B.; The Stroke Data Bank: Design, methods, and baseline characteristics. Stroke 1988,19(5),547-554","journal-title":"Stroke"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/ana.410250410","volume":"25","author":"Sacco R.L.","year":"1989","unstructured":"Sacco R.L.; Ellenberg J.H.; Mohr J.P.; Tatemichi T.K.; Hier D.B.; Price T.R.; Wolf P.A.; Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 1989,25(4),382-390","journal-title":"Ann Neurol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"Adams H.P.","year":"1993","unstructured":"Adams H.P.; Bendixen B.H.; Kappelle L.J.; Biller J.; Love B.B.; Gordon D.L.; Marsh E.E.; Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993,24(1),35-41","journal-title":"Stroke"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1161\/01.STR.0000106137.42649.AB","volume":"35","author":"Cramer S.C.","year":"2004","unstructured":"Cramer S.C.; Rordorf G.; Maki J.H.; Kramer L.A.; Grotta J.C.; Burgin W.S.; Hinchey J.A.; Benesch C.; Furie K.L.; Lutsep H.L.; Kelly E.; Longstreth W.T.; Increased pelvic vein thrombi in cryptogenic stroke: Results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. Stroke 2004,35(1),46-50","journal-title":"Stroke"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jcin.2009.05.010","volume":"2","author":"Rigatelli G.","year":"2009","unstructured":"Rigatelli G.; Aggio S.; Cardaioli P.; Braggion G.; Giordan M.; Dell\u2019avvocata F.; Chinaglia M.; Rigatelli G.; Roncon L.; Chen J.P.; Left atrial dysfunction in patients with patent foramen ovale and atrial septal aneurysm: An alternative concurrent mechanism for arterial embolism? JACC Cardiovasc Interv 2009,2(7),655-662","journal-title":"JACC Cardiovasc Interv"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.2017.1928","volume":"317","author":"Jain A.","year":"2017","unstructured":"Jain A.; Cifu A.S.; Antithrombotic therapy for venous thromboembolic disease. JAMA 2017,317(19),2008-2009","journal-title":"JAMA"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1212\/WNL.0b013e3182a08d59","volume":"81","author":"Kent D.M.","year":"2013","unstructured":"Kent D.M.; Ruthazer R.; Weimar C.; Mas J.L.; Serena J.; Homma S.; Di Angelantonio E.; Di Tullio M.R.; Lutz J.S.; Elkind M.S.; Griffith J.; Jaigobin C.; Mattle H.P.; Michel P.; Mono M.L.; Nedeltchev K.; Papetti F.; Thaler D.E.; An index to identify stroke-related vs. incidental patent foramen ovale in cryptogenic stroke. Neurology 2013,81(7),619-625","journal-title":"Neurology"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","volume":"378","author":"Hart R.G.","year":"2018","unstructured":"Hart R.G.; Sharma M.; Mundl H.; Kasner S.E.; Bangdiwala S.I.; Berkowitz S.D.; Swaminathan B.; Lavados P.; Wang Y.; Wang Y.; Davalos A.; Shamalov N.; Mikulik R.; Cunha L.; Lindgren A.; Arauz A.; Lang W.; Czlonkowska A.; Eckstein J.; Gagliardi R.J.; Amarenco P.; Ameriso S.F.; Tatlisumak T.; Veltkamp R.; Hankey G.J.; Toni D.; Bereczki D.; Uchiyama S.; Ntaios G.; Yoon B.W.; Brouns R.; Endres M.; Muir K.W.; Bornstein N.; Ozturk S.; O\u2019Donnell M.J.; De Vries Basson M.M.; Pare G.; Pater C.; Kirsch B.; Sheridan P.; Peters G.; Weitz J.I.; Peacock W.F.; Shoamanesh A.; Benavente O.R.; Joyner C.; Themeles E.; Connolly S.J.; Investigators N.E.; Rivaroxaban for stroke prevention after embolic stroke of undetermined source. N Engl J Med 2018,378(23),2191-2201","journal-title":"N Engl J Med"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S1474-4422(18)30319-3","volume":"17","author":"Kasner S.E.","year":"2018","unstructured":"Kasner S.E.; Swaminathan B.; Lavados P.; Sharma M.; Muir K.; Veltkamp R.; Ameriso S.F.; Endres M.; Lutsep H.; Mess\u00e9 S.R.; Spence J.D.; Nedeltechev K.; Perera K.; Santo G.; Olavarria V.; Lindgren A.; Bangdiwala S.; Shoamanesh A.; Berkowitz S.D.; Mundl H.; Connolly S.J.; Hart R.G.; Investigators N.E.; Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial. Lancet Neurol 2018,17(12),1053-1060","journal-title":"Lancet Neurol"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"I9","DOI":"10.1161\/01.CIR.0000078469.07362.E6","volume":"107","author":"Anderson F.A.","year":"2003","unstructured":"Anderson F.A.; Spencer F.A.; Risk factors for venous thromboembolism. Circulation 2003,107(23)(Suppl. 1),I9-I16","journal-title":"Circulation"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1093\/eurheartj\/ehv252","volume":"36","author":"Kent D.M.","year":"2015","unstructured":"Kent D.M.; Dahabreh I.J.; Ruthazer R.; Furlan A.J.; Weimar C.; Serena J.; Meier B.; Mattle H.P.; Di Angelantonio E.; Paciaroni M.; Schuchlenz H.; Homma S.; Lutz J.S.; Thaler D.E.; Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: An individual participant data meta-analysis. Eur Heart J 2015,36(35),2381-2389","journal-title":"Eur Heart J"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","volume":"45","author":"Kernan W.N.","year":"2014","unstructured":"Kernan W.N.; Ovbiagele B.; Black H.R.; Bravata D.M.; Chimowitz M.I.; Ezekowitz M.D.; Fang M.C.; Fisher M.; Furie K.L.; Heck D.V.; Johnston S.C.; Kasner S.E.; Kittner S.J.; Mitchell P.H.; Rich M.W.; Richardson D.; Schwamm L.H.; Wilson J.A.; Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 2014,45(7),2160-2236","journal-title":"Stroke"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"Patel M.R.","year":"2011","unstructured":"Patel M.R.; Mahaffey K.W.; Garg J.; Pan G.; Singer D.E.; Hacke W.; Breithardt G.; Halperin J.L.; Hankey G.J.; Piccini J.P.; Becker R.C.; Nessel C.C.; Paolini J.F.; Berkowitz S.D.; Fox K.A.; Califf R.M.; Investigators R.A.; Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011,365(10),883-891","journal-title":"N Engl J Med"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"Granger C.B.","year":"2011","unstructured":"Granger C.B.; Alexander J.H.; McMurray J.J.; Lopes R.D.; Hylek E.M.; Hanna M.; Al-Khalidi H.R.; Ansell J.; Atar D.; Avezum A.; Bahit M.C.; Diaz R.; Easton J.D.; Ezekowitz J.A.; Flaker G.; Garcia D.; Geraldes M.; Gersh B.J.; Golitsyn S.; Goto S.; Hermosillo A.G.; Hohnloser S.H.; Horowitz J.; Mohan P.; Jansky P.; Lewis B.S.; Lopez-Sendon J.L.; Pais P.; Parkhomenko A.; Verheugt F.W.; Zhu J.; Wallentin L.; Committees A.; Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011,365(11),981-992","journal-title":"N Engl J Med"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"Giugliano R.P.","year":"2013","unstructured":"Giugliano R.P.; Ruff C.T.; Braunwald E.; Murphy S.A.; Wiviott S.D.; Halperin J.L.; Waldo A.L.; Ezekowitz M.D.; Weitz J.I.; \u0160pinar J.; Ruzyllo W.; Ruda M.; Koretsune Y.; Betcher J.; Shi M.; Grip L.T.; Patel S.P.; Patel I.; Hanyok J.J.; Mercuri M.; Antman E.M.; Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2013,369(22),2093-2104","journal-title":"N Engl J Med"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/ccd.24511","volume":"82","author":"Wallenborn J.","year":"2013","unstructured":"Wallenborn J.; Bertog S.C.; Franke J.; Steinberg D.H.; Majunke N.; Wilson N.; Wunderlich N.; Sievert H.; Recurrent events after percutaneous closure of patent foramen ovale. Catheter Cardiovasc Interv 2013,82(4),541-546","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","volume":"368","author":"Meier B.","year":"2013","unstructured":"Meier B.; Kalesan B.; Mattle H.P.; Khattab A.A.; Hildick-Smith D.; Dudek D.; Andersen G.; Ibrahim R.; Schuler G.; Walton A.S.; Wahl A.; Windecker S.; J\u00fcni P.; Investigators P.C.T.; Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med 2013,368(12),1083-1091","journal-title":"N Engl J Med"},{"key":"ref=77","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4471-4987-3_24","author":"Khattab A.A.M.B.","year":"2015","unstructured":"Khattab A.A.M.B.;  The PC trial: An effective treatment not demonstrating effective power Patent Foramen Ovale; Amin, Z; Tobis, J; Sievert, H 2015","journal-title":"The PC trial: An effective treatment not demonstrating effective power Patent Foramen Ovale; Amin, Z; Tobis, J; Sievert, H"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","volume":"368","author":"Carroll J.D.","year":"2013","unstructured":"Carroll J.D.; Saver J.L.; Thaler D.E.; Smalling R.W.; Berry S.; MacDonald L.A.; Marks D.S.; Tirschwell D.L.; Investigators R.; Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med 2013,368(12),1092-1100","journal-title":"N Engl J Med"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1093\/eurheartj\/eht285","volume":"34","author":"Rengifo-Moreno P.","year":"2013","unstructured":"Rengifo-Moreno P.; Palacios I.F.; Junpaparp P.; Witzke C.F.; Morris D.L.; Romero-Corral A.; Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: A systematic review and meta-analysis of randomized controlled trials. Eur Heart J 2013,34(43),3342-3352","journal-title":"Eur Heart J"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.jcin.2013.08.001","volume":"6","author":"Khan A.R.","year":"2013","unstructured":"Khan A.R.; Bin Abdulhak A.A.; Sheikh M.A.; Khan S.; Erwin P.J.; Tleyjeh I.; Khuder S.; Eltahawy E.A.; Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: A systematic review and meta-analysis. JACC Cardiovasc Interv 2013,6(12),1316-1323","journal-title":"JACC Cardiovasc Interv"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.jacc.2015.12.023","volume":"67","author":"Kent D.M.","year":"2016","unstructured":"Kent D.M.; Dahabreh I.J.; Ruthazer R.; Furlan A.J.; Reisman M.; Carroll J.D.; Saver J.L.; Smalling R.W.; J\u00fcni P.; Mattle H.P.; Meier B.; Thaler D.E.; Device closure of patent foramen ovale after stroke: Pooled analysis of completed randomized trials. J Am Coll Cardiol 2016,67(8),907-917","journal-title":"J Am Coll Cardiol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.1093\/eurheartj\/eht283","volume":"34","author":"Hornung M.","year":"2013","unstructured":"Hornung M.; Bertog S.C.; Franke J.; Id D.; Taaffe M.; Wunderlich N.; Vaskelyte L.; Hofmann I.; Sievert H.; Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale. Eur Heart J 2013,34(43),3362-3369","journal-title":"Eur Heart J"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/eurheartj\/ehu292","volume":"36","author":"Stortecky S.","year":"2015","unstructured":"Stortecky S.; da Costa B.R.; Mattle H.P.; Carroll J.; Hornung M.; Sievert H.; Trelle S.; Windecker S.; Meier B.; J\u00fcni P.; Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: A network meta-analysis. Eur Heart J 2015,36(2),120-128","journal-title":"Eur Heart J"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1016\/j.jcin.2017.09.002","volume":"10","author":"Mojadidi M.K.","year":"2017","unstructured":"Mojadidi M.K.; Elgendy A.Y.; Elgendy I.Y.; Mahmoud A.N.; Elbadawi A.; Eshtehardi P.; Patel N.K.; Wayangankar S.; Tobis J.M.; Meier B.; Transcatheter Patent Foramen Ovale closure after cryptogenic stroke: An updated meta-analysis of randomized trials. JACC Cardiovasc Interv 2017,10(21),2228-2230","journal-title":"JACC Cardiovasc Interv"},{"key":"ref=85","author":"Sitwala P.","year":"2018.","unstructured":"Sitwala P.; Khalid M.F.; Khattak F.; Bagai J.; Bhogal S.; Ladia V.; Mukherjee D.; Daggubati R.; Paul T.K.; Percutaneous closure of patent foramen ovale in patients with cryptogenic stroke - An updated comprehensive meta-analysis. Cardiovasc Revasc Med 2018.","journal-title":"Cardiovasc Revasc Med"},{"key":"ref=86","year":"2016.","unstructured":"FDA website October 28 Amplatzer PFO Occluder P120021. 2016.","journal-title":"FDA website October 28"},{"key":"ref=87","year":"2016.","unstructured":"GORE\u00ae CARDIOFORM Septal Occluder - P050006\/S060. 2016."},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1177\/1747493017743062","volume":"13","author":"Wein T.","year":"2018","unstructured":"Wein T.; Lindsay M.P.; Cote R.; Foley N.; Berlingieri J.; Bhogal S.; Bourgoin A.; Buck B.H.; Cox J.; Davidson D.; Dowlatshahi D.; Douketis J.; Falconer J.; Field T.; Gioia L.; Gubitz G.; Habert J.; Jaspers S.; Lum C.; McNamara Morse D.; Pageau P.; Rafay M.; Rodgerson A.; Semchuk B.; Sharma M.; Shoamanesh A.; Tamayo A.; Smitko E.; Gladstone D.J.; Canadian stroke\nbest practice recommendations: Secondary prevention of stroke,\nsixth edition practice guidelines, update 2017.  Int J Stroke 2018,13(4),420-443","journal-title":"Int J Stroke"},{"key":"ref=89","first-page":"21","volume":"1","author":"Pristipino C.","year":"2010","unstructured":"Pristipino C.; Toni D.; Violini R.; Regional consensus document on the indication to percutaneous closure of patent foramen ovale in the presence of cryptogenic stroke. G Ital Cardiol Invasiva 2010,1,21-31","journal-title":"G Ital Cardiol Invasiva"},{"key":"ref=90","unstructured":"[IPG472], I p g, Percutaneous closure of patent foramen ovale to\nprevent recurrent cerebral embolic events, 2013 December,","journal-title":"[IPG472], I p g, Percutaneous closure of patent foramen ovale to\nprevent recurrent cerebral embolic events,"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1161\/STR.0000000000000074","volume":"46","author":"Powers W.J.","year":"2015","unstructured":"Powers W.J.; Derdeyn C.P.; Biller J.; Coffey C.S.; Hoh B.L.; Jauch E.C.; Johnston K.C.; Johnston S.C.; Khalessi A.A.; Kidwell C.S.; Meschia J.F.; Ovbiagele B.; Yavagal D.R.; 2015 American Heart Association\/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association. Stroke 2015,46(10),3020-3035","journal-title":"Stroke"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","volume":"44","author":"Jauch E.C.","year":"2013","unstructured":"Jauch E.C.; Saver J.L.; Adams H.P.; Bruno A.; Connors J.J.; Demaerschalk B.M.; Khatri P.; McMullan P.W.; Qureshi A.I.; Rosenfield K.; Scott P.A.; Summers D.R.; Wang D.Z.; Wintermark M.; Yonas H.; Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 2013,44(3),870-947","journal-title":"Stroke"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/ccd.24535","volume":"80","author":"Marmagkiolis K.","year":"2012","unstructured":"Marmagkiolis K.; Hakeem A.; Cilingiroglu M.; Bailey S.R.; Ruiz C.; Hijazi Z.M.; Herrmann H.C.; Zajarias A.; Goldberg S.L.; Feldman T.; The Society for Cardiovascular Angiography and Interventions Structural Heart Disease Early Career Task Force survey results: Endorsed by the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv 2012,80(4),706-711","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/ccd.28111","volume":"93","author":"Horlick E.","year":"2019","unstructured":"Horlick E.; Kavinsky C.J.; Amin Z.; Boudoulas K.D.; Carroll J.D.; Hijazi Z.M.; Leifer D.; Lutsep H.L.; Rhodes J.F.; Tobis J.M.; SCAI expert consensus statement on operator and institutional requirements for PFO closure for secondary prevention of paradoxical embolic stroke: The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Catheter Cardiovasc Interv 2019,93(5),859-874","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jacc.2006.02.057","volume":"48","author":"Jux C.","year":"2006","unstructured":"Jux C.; Bertram H.; Wohlsein P.; Bruegmann M.; Paul T.; Interventional atrial septal defect closure using a totally bioresorbable occluder matrix: Development and preclinical evaluation of the BioSTAR device. J Am Coll Cardiol 2006,48(1),161-169","journal-title":"J Am Coll Cardiol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1161\/CIRCULATIONAHA.106.664672","volume":"114","author":"Mullen M.J.","year":"2006","unstructured":"Mullen M.J.; Hildick-Smith D.; De Giovanni J.V.; Duke C.; Hillis W.S.; Morrison W.L.; Jux C.; BioSTAR Evaluation STudy (BEST): a prospective, multicenter, phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial-level shunts. Circulation 2006,114(18),1962-1967","journal-title":"Circulation"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.4244\/EIJ-D-17-00006","volume":"13","author":"Sigler M.","year":"2018","unstructured":"Sigler M.; S\u00f6derberg B.; Schmitt B.; Mellmann A.; Bernhard J.; Carag Bioresorbable Septal Occluder (CBSO): Histopathology of experimental implants. EuroIntervention 2018,13(14),1655-1661","journal-title":"EuroIntervention"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1161\/STROKEAHA.117.020030","volume":"49","author":"Ntaios G.","year":"2018","unstructured":"Ntaios G.; Papavasileiou V.; Sagris D.; Makaritsis K.; Vemmos K.; Steiner T.; Michel P.; Closure of Patent Foramen Ovale versus medical therapy in patients with cryptogenic stroke or transient ischemic attack: updated systematic review and meta-analysis. Stroke 2018,49(2),412-418","journal-title":"Stroke"}],"container-title":["Cardiovascular &amp; Hematological Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/178959","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/178959\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/178959","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T15:46:45Z","timestamp":1615391205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/178959\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,15]]},"references-count":98,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,10,15]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871525718666200203111641","relation":{},"ISSN":["1871-5257"],"issn-type":[{"value":"1871-5257","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,15]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-09-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}